Does FRUQUINTINIB Cause Hyperkeratosis? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Hyperkeratosis have been filed in association with FRUQUINTINIB (Fruzaqla). This represents 0.4% of all adverse event reports for FRUQUINTINIB.
9
Reports of Hyperkeratosis with FRUQUINTINIB
0.4%
of all FRUQUINTINIB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Hyperkeratosis From FRUQUINTINIB?
Of the 9 reports, 2 (22.2%) required hospitalization.
Is Hyperkeratosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FRUQUINTINIB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does FRUQUINTINIB Cause?
Death (647)
Fatigue (366)
Colon cancer (277)
Blood pressure increased (223)
Diarrhoea (213)
Colorectal cancer metastatic (212)
Decreased appetite (184)
Asthenia (178)
Dysphonia (176)
Off label use (133)
What Other Drugs Cause Hyperkeratosis?
CABOZANTINIB S-MALATE (411)
ADALIMUMAB (332)
SUNITINIB MALATE (170)
ETANERCEPT (168)
SORAFENIB (150)
METHOTREXATE (149)
VEMURAFENIB (145)
REGORAFENIB (136)
RIPRETINIB (124)
RITUXIMAB (121)
Which FRUQUINTINIB Alternatives Have Lower Hyperkeratosis Risk?
FRUQUINTINIB vs FULVESTRANT
FRUQUINTINIB vs FURAZOLIDONE
FRUQUINTINIB vs FUROSEMIDE
FRUQUINTINIB vs FUROSEMIDE\SPIRONOLACTONE
FRUQUINTINIB vs FUSIDATE